Archive: January 2018
Hepatitis B
Hepatitis B Virus Infection and Organ Transplantation
Walid S. Ayoub, MD, Paul Martin, MD, and Kalyan Ram Bhamidimarri, MD
Abstract: Hepatitis B virus (HBV) infection remains an important cause of liver disease and continues to present several unique challenges in organ transplantation despite the […]
IBD
Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease
Alyssa M. Parian, MD, and Mark G. Lazarev, MD
Abstract: The serrated neoplasia pathway is thought to account for up to 30% of sporadic colorectal cancer, but its role in inflammatory bowel disease (IBD)-related colorectal […]
Disaccharidase Deficiency
Variable Use of Disaccharidase Assays When Evaluating Abdominal Pain
Stanley A. Cohen, MD, and Hannah Oloyede, MS
Abstract: Background and Aims: Patients with a disaccharidase deficiency typically present with abdominal discomfort and often with diarrhea. However, disaccharidase deficiency is often overlooked as […]
IBS
The Role of Gut-Brain Interactions in Influencing Symptoms of Irritable Bowel Syndrome
Emeran A. Mayer, MD, PhD
G&H What is the evidence to support a role of the microbiome in the pathogenesis of irritable bowel syndrome? EM Four recent studies have demonstrated […]
IBD
Pain Management in Patients With Inflammatory Bowel Disease
Eva Szigethy, MD, PhD
G&H How prevalent are acute and chronic pain in patients with inflammatory bowel disease? ES Acute pain, such as abdominal distress in the context of […]
Endoscopy
Endoscopic Mucosal Resection Vs Endoscopic Submucosal Dissection for Colon Polyps
Peter V. Draganov, MD
G&H What endoscopic techniques are currently available for the removal of colon polyps? PD Currently, the main endoscopic techniques that are available for the removal […]
Practice Management
Update on Relative Value Units and the Cognitive Physician Visit
Seymour Katz, MD, and Eileen Petrilak
In a previous opinion piece, we examined how the Medicare Resource-Based Relative Value Scale undervalued cognitive office efforts, particularly the inflammatory bowel disease (IBD) office […]
Hepatology
Emerging Therapeutic Targets for Hepatitis Delta Virus Infection
Jeffrey S. Glenn, MD, PhD
G&H How prevalent is hepatitis delta virus infection in the United States and worldwide? JG Estimates are that approximately 70,000 to 100,000 people in the United […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
US Food and Drug Administration Approves Infliximab Biosimilar On December 14, 2017, the US Food and Drug Administration (FDA) approved the infliximab (Remicade, Janssen) biosimilar infliximab-qbtx […]
Letter From the Editor
Letter From the Editor: Pain Management
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
How should we manage our gastroenterology and hepatology patients who are in pain? This question has become particularly timely and increasingly important with the recent opioid […]